Skin inflammation that progresses to circulatory shock is most often attributed to infection as the first hypothesis. Fluids, antimicrobial drugs, and surgical debridement are sometimes necessary. However, non-infectious causes should be considered in a patient undergoing dialysis. Differentiating between cellulitis and calciphylaxis or calcific uremic arteriolopathy (CUA) is challenging; however, the mortality rate associated with CUA is generally high. We report the case of a woman with end-stage chronic kidney disease undergoing dialysis, who complained of lower abdominal pain. The patient presented with subcutaneous infiltration and painful erythematous skin lesions in the hypogastric region. Initially, erysipelas was suspected, and antibiotic treatment was initiated. Extensive surgical debridement of the necrotic tissue was urgently performed. Histopathological examination revealed calcifications in the wall of small vessels. The patient’s condition worsened within 24 h to refractory shock, ultimately leading to death from circulatory shock.
References
[1]
Nigwekar, S.U. (2017) Calciphylaxis. Current Opinion in Nephrology and Hypertension, 26, 276-281. https://doi.org/10.1097/mnh.0000000000000328
[2]
Selye, H., Gentile, G. and Prioreschi, P. (1961) Cutaneous Molt Induced by Calciphylaxis in the Rat. Science, 134, 1876-1877. https://doi.org/10.1126/science.134.3493.1876
[3]
Moe, S.M. and Chen, N.X. (2008) Mechanisms of Vascular Calcification in Chronic Kidney Disease. Journal of the American Society of Nephrology, 19, 213-216. https://doi.org/10.1681/asn.2007080854
[4]
Nigwekar, S.U., Thadhani, R. and Brandenburg, V.M. (2018) Calciphylaxis. New England Journal of Medicine, 378, 1704-1714. https://doi.org/10.1056/nejmra1505292
[5]
Nigwekar, S.U., Bloch, D.B., Nazarian, R.M., Vermeer, C., Booth, S.L., Xu, D., et al. (2017) Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. Journal of the American Society of Nephrology, 28, 1717-1722. https://doi.org/10.1681/asn.2016060651
[6]
Chen, N.X., O’Neill, K., Akl, N.K. and Moe, S.M. (2014) Adipocyte Induced Arterial Calcification Is Prevented with Sodium Thiosulfate. Biochemical and Biophysical Research Communications, 449, 151-156. https://doi.org/10.1016/j.bbrc.2014.05.005
[7]
Nigwekar, S.U., Zhao, S., Wenger, J., Hymes, J.L., Maddux, F.W., Thadhani, R.I., et al. (2016) A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. Journal of the American Society of Nephrology, 27, 3421-3429. https://doi.org/10.1681/asn.2015091065
[8]
Bajaj, R., Courbebaisse, M., Kroshinsky, D., Thadhani, R.I. and Nigwekar, S.U. (2018) Calciphylaxis in Patients with Normal Renal Function: A Case Series and Systematic Review. Mayo Clinic Proceedings, 93, 1202-1212. https://doi.org/10.1016/j.mayocp.2018.06.001
[9]
Colboc, H., Moguelet, P., Bazin, D., Carvalho, P., Dillies, A., Chaby, G., et al. (2019) Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients with Calcific Uremic Arteriolopathy. JAMA Dermatology, 155, 789-796. https://doi.org/10.1001/jamadermatol.2019.0381
[10]
Garcia, C.P., Roson, E., Peon, G., Abalde, M.T. and De La Torre, C. (2013) Calciphylaxis Treated with Sodium Thiosulfate: Report of Two Cases. Dermatology Online Journal, 19, Article 19616. https://doi.org/10.5070/d3199019616